TP53 and neoplasm: Interestingly, we observed an enrichment of genes associated with a loss of TP53 signaling in poorly differentiated tumor foci compared to adenocarcinoma despite no distinguishing loss of function mutations or change in Trp53 expression (Supplementary Fig. 3a, c, d).